Brief: Freeline Reports Full Year 2022 Financial Results

Freeline Therapeutics Holdings

04/04/2023 12:18

April 4 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE REPORTS FULL YEAR 2022 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
    * FREELINE THERAPEUTICS HOLDINGS PLC FY LOSS PER SHARE $1.50
    * FREELINE THERAPEUTICS HOLDINGS PLC - INITIAL CLINICAL DATA
ON
FLT201 EXPECTED IN Q3 2023
    * FREELINE THERAPEUTICS HOLDINGS PLC - RESTRUCTURING
ORGANIZATION
AND PAUSING DEVELOPMENT OF FLT190 TO EXTEND CASH RUNWAY INTO Q2
2024
    * FREELINE THERAPEUTICS HOLDINGS PLC - PROPOSED TO REDUCE
ITS
WORKFORCE BY NEARLY 30 PERCENT, BRINGING ITS HEADCOUNT TO
APPROXIMATELY 65 EMPLOYEES
    * FREELINE THERAPEUTICS HOLDINGS PLC - AS OF DECEMBER 31,
2022,
UNRESTRICTED CASH AND CASH EQUIVALENTS WERE $47.3 MILLION

Source text for Eikon:  ID:nGNX6cnG7z 
Further company coverage:  FRLN.O 

 ((reuters.briefs@thomsonreuters.com;))